全文获取类型
收费全文 | 2787篇 |
免费 | 185篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 105篇 |
妇产科学 | 48篇 |
基础医学 | 287篇 |
口腔科学 | 88篇 |
临床医学 | 276篇 |
内科学 | 616篇 |
皮肤病学 | 248篇 |
神经病学 | 142篇 |
特种医学 | 320篇 |
外科学 | 249篇 |
综合类 | 39篇 |
预防医学 | 231篇 |
眼科学 | 38篇 |
药学 | 153篇 |
中国医学 | 10篇 |
肿瘤学 | 148篇 |
出版年
2023年 | 15篇 |
2022年 | 19篇 |
2021年 | 49篇 |
2020年 | 30篇 |
2019年 | 50篇 |
2018年 | 80篇 |
2017年 | 51篇 |
2016年 | 67篇 |
2015年 | 79篇 |
2014年 | 90篇 |
2013年 | 88篇 |
2012年 | 118篇 |
2011年 | 128篇 |
2010年 | 93篇 |
2009年 | 103篇 |
2008年 | 117篇 |
2007年 | 149篇 |
2006年 | 129篇 |
2005年 | 129篇 |
2004年 | 104篇 |
2003年 | 98篇 |
2002年 | 89篇 |
2001年 | 89篇 |
2000年 | 92篇 |
1999年 | 68篇 |
1998年 | 95篇 |
1997年 | 83篇 |
1996年 | 68篇 |
1995年 | 67篇 |
1994年 | 51篇 |
1993年 | 51篇 |
1992年 | 47篇 |
1991年 | 33篇 |
1990年 | 36篇 |
1989年 | 53篇 |
1988年 | 52篇 |
1987年 | 34篇 |
1986年 | 30篇 |
1985年 | 33篇 |
1984年 | 23篇 |
1983年 | 19篇 |
1982年 | 22篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 21篇 |
1976年 | 14篇 |
1975年 | 17篇 |
1972年 | 5篇 |
排序方式: 共有3053条查询结果,搜索用时 15 毫秒
51.
JI Tang M Back T Shakespeare JJ Lu R Mukherjee C Wynne S Liang 《Journal of Medical Imaging and Radiation Oncology》2005,49(5):390-395
The aims were to determine the median survival and prognostic factors of patients with central nervous system (CNS) metastases managed with whole‐brain radiation therapy (WBRT), and to explore selection criteria in recently published clinical trials using aggressive interventions in CNS metastases. A retrospective audit was performed on patients managed with WBRT for CNS metastases. Potential prognostic factors were recorded and analysed for their association with survival duration. The proportion of patients with these factors was also compared with those of patients managed under three recently reported studies investigating aggressive interventions, such as radiosurgery and chemotherapy for CNS metastases. Seventy‐three patients were treated with WBRT for cerebral metastases over a 12‐month period. The median survival of the population was 3.4 months (95% confidence interval: 2.7–4.1), with 6‐ and 12‐month survival rates of 30 and 18%, respectively. Significant prognostic factors for prolonged median survival were Eastern Cooperative Oncology Group status 0–2 (P = 0.015), Medical Research Council neurological functional status 0–1 (P = 0.006), and Recursive Partitioning Analysis Class 2 versus Class 3 (P = 0.020). On multivariate analysis, younger patient age (P = 0.02) and better performance status (P < 0.01) were associated with improved outcome. When comparing these characteristics with selected published studies, our study cohort demonstrated a higher proportion of patients with poor performance status, a greater number of metastases per patient and a higher incidence of extracranial disease. This reflects the selected nature of patients in these published studies. Central nervous system metastases confer a poor prognosis and, for the majority of patients, aggressive interventions are unlikely to improve survival. The use of potentially toxic and expensive treatments should be reserved for those few in whom these studies have shown a potential benefit. 相似文献
52.
53.
54.
Análisis y minimización del riesgo de rotura de stock aplicado a la gestión en farmacia hospitalaria
José María Maestre Torreblanca Beatriz Isla Tejera María Isabel Fernández García José Ramón del Prado Llergo Teodoro Álamo Cantarero Eduardo Fernández Camacho 《Farmacia hospitalaria》2012,36(3):130-134
ObjectiveTo determine how many dispensary drugs should be in the safety stock in a tertiary hospital in accordance with the risk level and the number of days that the hospital is able to withstand a stockout.MethodsWe statistically analysed the infliximab order recorded over a period of 120 days. This drug is relevant for this study as it is costly and is immediately supplied to the clinic. Using the data records for purchasing and dispensing in our department, we created a table to compare the level of risk assumed with the number of units in stock and the number of days that the safety stock should last. In addition, we calculated how much stock there should be in accordance with different heuristic rules used by pharmacy departments.ResultsIn the period being studied, the daily order was 11.4 ± 14.8 units of infliximab. Using the methodology proposed, we discovered that there should be 79 units in the safety stock. Other hospital rules determine values of 47 and 119 units.ConclusionsThe method proposed allows us to discover the risk level that is assumed when selecting the safety stock. Therefore, we are able to design a safety stock policy consistent with the risk level adopted. Under certain assumptions the safety stock quota provided by this method could be reduced. Lastly, there is a notable difference between the safety stock values suggested by different rules, as it has been shown in this article. 相似文献
55.
56.
57.
58.
59.